Link Cell Therapies Announces $60M Series A Financing Back to Home Tweet SOUTH SAN FRANCISCO, CA, Link Cell Therapies, an oncology cell therapy company, announced its official launch from stealth with a$60 million Series A financing. Link Cell Therapies, an oncology cell therapy company, announced its official launch from stealth with a $60 million Series A financing that was led by Johnson & Johnson, through its corporate venture capital organization, Johnson & Johnson Innovation - JJDC, Inc. , with ...